Русский
Super-selective prostatic artery embolization for bph treatment.
DOI: https://dx.doi.org/10.18565/urology.2019.3.134-141
V.K. Karpov, S.A. Kapranov, B.M. Shaparov, B.E. Osmolovskiy, D.M. Kamalov, A.A. Kamalov
1 Lomonosov Moscow State University, Faculty of Fundamental Medicine, Urology and Andrology Department (Director – academician, MD Kamalov A.A.), Moscow, Russia; 2 Moscow Research and Education Center of the Lomonosov Moscow State University (Director – academician, MD Kamalov A.A.), Moscow, Russia; 3 Pirogov Russian National Research Medical University (Director – academician, MD Lukyanov S.A.), Moscow, Russia; 4 GBUZ «GKB №31 DZM» (Director – MD Ephremova N.M.), Moscow, Russia
Benign prostatic hyperplasia (BPH) is one of the most common diseases of the genitourinary system. BPH prevalence increases in men with advancing age, highlighting the necessity of minimally invasive surgical procedure including super-selective prostatic artery embolization (PAE). The current role of the PAE for BPH treatment according to recent national and international publications is discussed in this review. The data from the largest studies are structured and presented along with our experience in PAE. In addition, a need to continue research on this topic is underlined.
Keywords: super-selective embolization of prostatic arteries, PAE, minimally invasive surgical procedures, embolization, BPH
About the Autors
Corresponding author: Karpov V.K. – Ph.D., Lomonosov Moscow State University, Faculty of Fundamental Medicine, Urology and Andrology Department, Moscow, Russia; e-mail: vk_karpov@mail.ru
Similar Articles
